WaveSense Jazz Blood Glucose Monitoring System

WaveSense Jazz Blood Glucose Monitoring System is an FDA 510(k)-cleared medical device (K241304) manufactured by Agamatrix. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 5, 2024. Regulation: 8.